Early research (Phase 1)Study completedNCT03301207
What this trial is testing
Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy
Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLC 25